Abstract:Severe traumatic brain injury (TBI) induces seizures or status epilepticus (SE) in 20-30% of patients during the acute phase. We hypothesized that severe TBI induced with lateral fluid-percussion injury (FPI) triggers post-impact SE. Adult Sprague-Dawley male rats were anesthetized with isoflurane and randomized into the sham-operated experimental control or lateral FPI-induced severe TBI groups. Electrodes were implanted right after impact or sham-operation, then videoelectroencephalogram (EEG) monitoring was… Show more
“…It is well known that animals with lateral FPI lose weight, which apparently relates to brain injury-induced loss of consciousness and motor impairment, but also to nonconvulsive status epilepticus, which can last for 3-4 days. 34 Thereafter, the body weight begins to increase, eventually reaching the level of age-matched sham-operated experimental controls and naive animals. Unexpectedly, we found that the weight loss was more pronounced and the weight gain slower in TBI+ rats than in TBI− rats.…”
Section: Discussionmentioning
confidence: 99%
“…We recently demonstrated that almost all animals with lateral FPI develop postinjury nonconvulsive status epilepticus, which is associated with both immediate (<24 hours) electrographic seizures, typically occurring within a few hours after impact, and early (<7 days) electrographic seizures, most of which are nonconvulsive and occur during D1-D4 after TBI. 34 Whether the "immediate post-impact seizure-like behavior" associates with electrographic characteristics of a seizure, thus belonging to the category of "immediate seizures," remains to be determined, however, despite the technical challenges related to EEG recordings immediately after the impact. Our findings revealed no association between acute seizure-like behavior and development of PTE, consistent with our previous study.…”
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
“…It is well known that animals with lateral FPI lose weight, which apparently relates to brain injury-induced loss of consciousness and motor impairment, but also to nonconvulsive status epilepticus, which can last for 3-4 days. 34 Thereafter, the body weight begins to increase, eventually reaching the level of age-matched sham-operated experimental controls and naive animals. Unexpectedly, we found that the weight loss was more pronounced and the weight gain slower in TBI+ rats than in TBI− rats.…”
Section: Discussionmentioning
confidence: 99%
“…We recently demonstrated that almost all animals with lateral FPI develop postinjury nonconvulsive status epilepticus, which is associated with both immediate (<24 hours) electrographic seizures, typically occurring within a few hours after impact, and early (<7 days) electrographic seizures, most of which are nonconvulsive and occur during D1-D4 after TBI. 34 Whether the "immediate post-impact seizure-like behavior" associates with electrographic characteristics of a seizure, thus belonging to the category of "immediate seizures," remains to be determined, however, despite the technical challenges related to EEG recordings immediately after the impact. Our findings revealed no association between acute seizure-like behavior and development of PTE, consistent with our previous study.…”
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
“…16 Previous studies reported that severe traumatic brain injury induced by lateral fluid-percussion injury to rats caused seizures and SE. 17,18 Co implanted in the motor cortex caused focal seizures. [19][20][21] Co binds to oxygen-binding molecules and causes functional hypoxia, triggers neuronal death, and increases expression of vascular endothelial growth factor.…”
Objective: To characterize neocortical onset status epilepticus (SE) in the C57BL/6J mouse. Methods: We induced SE by administering homocysteine 16-18 hours after cobalt (Co) implantation. SE was monitored by video and electroencephalography (EEG). We evaluated brain structure with magnetic resonance imaging (MRI). Neurodegeneration was evaluated 72 hours after SE using Fluoro-Jade C staining. Results: Cobalt triggered seizures in a dose-dependent manner (median effective dose, ED 50 = 0.78 mg) and the latency to peak seizure frequency shortened with increased dose. Animals developed SE after homocysteine administration. SE began with early intermittent focal seizures, consisting of frontal onset rhythmic spikewave discharges manifested as focal dystonia with clonus. These focal seizures then evolved into generalized continuous convulsive activity. Behavioral manifestations of SE included tonic stiffening, bilateral limb clonus, and bilateral tonic-clonic movements, which were accompanied by generalized rhythmic spike-wave discharges on EEG. After prolonged seizures, animals became comatose with intermittent bilateral myoclonic seizures or jerks. During this period, EEG showed seizures interspersed with generalized periodic discharges on a suppressed background. MRI obtained when animals were in a coma revealed edema, midline shift in frontal lobe around the Co implantation site, and ventricular effacement. Fluoro-Jade C staining revealed neurodegeneration in the cortex, amygdala, and thalamus. Significance: We have developed a mouse model of severe, refractory cortical-onset SE, consisting of convulsions merging into a coma, EEG patterns of cortical seizures, and injury, with evidence of widespread neocortical edema and damage. This model replicates many features of acute seizures and SE resulting from traumatic brain injury, subarachnoid, and lobar hemorrhage.
“…The poor performance could relate to dizziness and sedation, which are well-known side effects of clomipramine in humans [61]. Recently, we found that rats with lateral FPI have non-convulsive status epilepticus lasting approximately 3 days [65]. Thus, some of our animals could still have had epileptiform activity when the clomipramine treatment was initiated.…”
We developed a pipeline for the discovery of transcriptomics-derived disease-modifying therapies and used it to validate treatments in vitro and in vivo that could be repurposed for TBI treatment. Desmethylclomipramine, ionomycin, sirolimus and trimipramine, identified by in silico LINCS analysis as candidate treatments modulating the TBI-induced transcriptomics networks, were tested in neuron-BV2 microglial co-cultures, using tumour necrosis factor α as a monitoring biomarker for neuroinflammation, nitrite for nitric oxide-mediated neurotoxicity and microtubule associated protein 2-based immunostaining for neuronal survival. Based on (a) therapeutic time window in silico, (b) blood-brain barrier penetration and water solubility, (c) anti-inflammatory and neuroprotective effects in vitro (p < 0.05) and (d) target engagement of Nrf2 target genes (p < 0.05), desmethylclomipramine was validated in a lateral fluid-percussion model of TBI in rats. Despite the favourable in silico and in vitro outcomes, in vivo assessment of clomipramine, which metabolizes to desmethylclomipramine, failed to demonstrate favourable effects on motor and memory tests. In fact, clomipramine treatment worsened the composite neuroscore (p < 0.05). Weight loss (p < 0.05) and prolonged upregulation of plasma cytokines (p < 0.05) may have contributed to the worsened somatomotor outcome. Our pipeline provides a rational stepwise procedure for evaluating favourable and unfavourable effects of systems-biology discovered compounds that modulate post-TBI transcriptomics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.